|
Index | - | P/E | - | EPS (ttm) | - | Insider Own | - | Shs Outstand | - | Perf Week | 4.62% |
Market Cap | - | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | - | Perf Month | -0.11% |
Income | - | PEG | - | EPS next Q | - | Inst Own | - | Short Float | - | Perf Quarter | 1.05% |
Sales | - | P/S | - | EPS this Y | - | Inst Trans | - | Short Ratio | - | Perf Half Y | 0.73% |
Book/sh | - | P/B | - | EPS next Y | - | ROA | - | Target Price | - | Perf Year | - |
Cash/sh | - | P/C | - | EPS next 5Y | - | ROE | - | 52W Range | 24.06 - 29.91 | Perf YTD | -6.76% |
Dividend | 0.04 | P/FCF | - | EPS past 5Y | - | ROI | - | 52W High | -12.87% | Beta | - |
Dividend % | 0.14% | Quick Ratio | - | Sales past 5Y | - | Gross Margin | - | 52W Low | 8.31% | ATR | 0.55 |
Employees | - | Current Ratio | - | Sales Q/Q | - | Oper. Margin | - | RSI (14) | 56.43 | Volatility | 1.05% 1.88% |
Optionable | No | Debt/Eq | - | EPS Q/Q | - | Profit Margin | - | Rel Volume | 0.17 | Prev Close | 25.49 |
Shortable | Yes | LT Debt/Eq | - | Earnings | - | Payout | - | Avg Volume | 107.73K | Price | 26.06 |
Recom | - | SMA20 | 4.01% | SMA50 | -0.83% | SMA200 | -0.11% | Volume | 18,401 | Change | 2.24% |
![]() |
|
![]() | ||||||
![]() | ||||||
|
||||||
![]() | ||||||
Under normal circumstances, the fund will invest at least 80% of its assets (plus any borrowings for investment purposes) in securities of U.S. health care companies. The fund adviser defines health care companies as companies included in the Global Industry Classification Standard health care sector. The fund will typically invest in 50 - 100 health care companies. The adviser generally seeks investments in companies that are developing new and effective medicines, as well as companies whose business models reduce costs or improve quality in health care systems. | ||||||
![]() | ||||||
![]() |
open in yahoo | open in marketwatch | open in google |
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite